decisionhealth Newsletters, Part B News - 2000 Issue 4 (April)
HCFA tweaks self-injectable policy at behest of Congress
Subscribe or sign in to view the full article.
Article Overview
This article covers a Medicare policy update from HCFA on self-administered drugs and the related billing considerations for physicians, physician assistants, and other clinicians. It is aimed at coders, billers, and reimbursement staff who need to understand the broad categories of guidance affecting office administration, incident-to billing, and chemotherapy-related administration policies.
Why This Topic Matters
The article helps readers understand a Medicare policy change that affects how self-injectable medications and administration services are billed, with potential impact on claim submission and carrier payment practices.
What You Will Learn
- The context for HCFA guidance on self-administered drug billing under Medicare
- How the article frames general Medicare billing considerations for drug administration
- The types of clinical situations discussed in relation to self-injectable medications
- How chemotherapy-related administration policies are discussed at a high level
Who Should Read This
- Medical coders
- Billing staff
- Reimbursement specialists
- Practice managers
- Physician office staff
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com